Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal-dose buprenorphine maintenance treatment in heroin use disorder
ChiCTR1900021739Phase 4Completed
- Sponsor
- Ningbo Addiction Research and Treatment Center
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buprenorphine in heroin addiction, sponsored by Ningbo Addiction Research and Treatment Center. Primary endpoint: Relapse status. Started May 2016; status: completed.
02
Drugs
buprenorphine
03
Conditions
heroin addiction
Beyond the preview
Go deeper on ChiCTR1900021739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021739.